EMA Application withdrawn: Sondelbay (teriparatide) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA has withdrawn the application for Sondelbay (teriparatide) by Accord Healthcare S.L.U. for osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Sondelbay (teriparatide)

Snippet

Status: Application withdrawn. Therapeutic area: Osteoporosis. MAH: Accord Healthcare S.L.U.